METTL3 enhanced the stability of pyruvate dehydrogenase kinase 4 (PDK4) and HK2 mRNAs in a METTL3-m6A-YTHDF1-dependent manner, ultimately promoting tumor growth and chemoresistance [116]. The gene discussed is METTL3; the disease is neoplasm.